---
figid: PMC6620914__zns9991217090011
figlink: /pmc/articles/PMC6620914/figure/F11/
number: Figure 11
caption: Schematic of GPR30-mediated signaling. GPR30, a G-protein-coupled receptor,
  activates heterotrimeric G-proteins, which in turn activates multiple effectors,
  including adenylyl cyclase (resulting in cAMP production), the phosphorylation of
  ERK1/2, and Src. The latter appears to be involved in the activation of transactivation
  of EGFRs via a G-protein-dependent pathway. The activated ERK by GPR30 agonist inhibits
  p-DAPK1 from dephosphorylating to the active form (DAPK1). This leads to the inhibition
  of active DAPK1 binding with the NR2B, and then phosphorylated NR2B at Ser-1303.
  The phosphorylated NR2B at Ser-1303 enhances the function of NMDARs, which causes
  the overload of Ca2+. The GPR30 is also shown to directly activate the PI3K/Akt
  survival signaling cascades.
pmcid: PMC6620914
papertitle: G-Protein-Coupled Receptor 30 Mediates Rapid Neuroprotective Effects of
  Estrogen via Depression of NR2B-Containing NMDA Receptors.
reftext: Shui-bing Liu, et al. J Neurosci. 2012 Apr 4;32(14):4887-4900.
pmc_ranked_result_index: '87073'
pathway_score: 0.9789706
filename: zns9991217090011.jpg
figtitle: GPR30-mediated signaling
year: '2012'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6620914__zns9991217090011.html
  '@type': Dataset
  description: Schematic of GPR30-mediated signaling. GPR30, a G-protein-coupled receptor,
    activates heterotrimeric G-proteins, which in turn activates multiple effectors,
    including adenylyl cyclase (resulting in cAMP production), the phosphorylation
    of ERK1/2, and Src. The latter appears to be involved in the activation of transactivation
    of EGFRs via a G-protein-dependent pathway. The activated ERK by GPR30 agonist
    inhibits p-DAPK1 from dephosphorylating to the active form (DAPK1). This leads
    to the inhibition of active DAPK1 binding with the NR2B, and then phosphorylated
    NR2B at Ser-1303. The phosphorylated NR2B at Ser-1303 enhances the function of
    NMDARs, which causes the overload of Ca2+. The GPR30 is also shown to directly
    activate the PI3K/Akt survival signaling cascades.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKACG
  - PRKAR1A
  - PRKACB
  - ADCY8
  - ADCY9
  - ADCY6
  - ADCY7
  - PIK3CD
  - PIK3CG
  - ADCY4
  - PRKACA
  - ADCY2
  - ADCY3
  - ADCY5
  - MAP2K1
  - MAP2K2
  - PIK3R6
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - PIK3CB
  - AKT3
  - PIK3R3
  - ADCY1
  - EGFR
  - MAPK3
  - MAPK1
  - GPER1
  - PRKAR2B
  - SRC
  - PRKAR1B
  - PRKAR2A
  - AKT2
  - ADCY10
  - AKT1
  - Cancer
genes:
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: GPR30
  symbol: GPR30
  source: hgnc_prev_symbol
  hgnc_symbol: GPER1
  entrez: '2852'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
